Biomarker-driven clinical research.
It’s elemental.

We are the world’s most comprehensive services organization for biomarker-driven therapeutic and diagnostic development.

Solutions S

Global Clinical Trials Gt Robust global reach with > 1,000 global clinical trial team Full-service, biomarker-driven trials for emerging and midstage biotech Seamless integration of specialty assays and complex biomarker data informatics EXPLORE

Global Specimen Logistics & Storage Gs Consistent real-time tissue processing in 55 countries Full trial support - kitting, logistics, real-time tracking and storage Over 25 million samples stored in all conditions, globally EXPLORE

Global Biomarker Assays Bm Full portfolio of specialty assays spanning DNA, RNA, protein, cell, and tissue Custom research to full-scale validation including CAP, CLIA, ISO Global footprint to deliver real-time assays EXPLORE

Biospecimens B Fully characterized healthy and disease-state tissue and fluids for research and assay controls Custom isolations for client specific needs EXPLORE

QuartzBio^SM Translational Informatics Ti Harmonize biomarker data from multiple labs and EDC Deep multiomic visualization and analysis expertise AI-derived multiomic signatures across data sets EXPLORE

Companion Diagnostics CDx Expert regulatory strategy development and execution Clinical utility and evidence for market access 100+ IVD pre-submissions and 250+ marketing clearances and approvals globally EXPLORE

Therapeutic Expertise Te

Oncology & Immuno-Oncology Io Executed over 350 oncology trials worldwide over 20 years Global Oncology Site Network for rapid study start up Dedicated oncology clinical trials team with > 10 years of experience on average EXPLORE

Neurology N De-risked drug development with precision medicine approaches Integrated regulatory, study design, site, and patient engagement strategy for rare neurological clinical trials EXPLORE

Autoimmune A Global immune monitoring solutions for any phase Novel immune assessment platform–EpiontisID–optimized for autoimmune indications Insights into complex disease biology through translational informatics and pathway analysis EXPLORE

Rare Disease R Maximized recruitment and retention with patient-centric approach Experience in executing over 50 rare disease indications Awarded “Best Orphan Drug CRO” for multiple consecutive years EXPLORE

Gene Therapy Gt Industry-leading expertise in AAV-based assay support from preclinical to full commercial use Excellence in trial design and execution; 100% data submission acceptance CDX development and commercialization for gene therapies EXPLORE

Biopharma Bp Full-service, biomarker-driven trials, commited to emerging and midstage biotech Specialty lab and biomarker informatics for any drug development application Team of 1,000 globally to delivering P1-P3 trials EXPLORE

Biomarker Capabilities Bc

Immune Monitoring Im Advanced assay solutions for complex science, logistics and costs effectiveness Globally redundant infrastructure Assay design that addresses science, logistics and cost EXPLORE

Tissue Biopsy Tp Full-service IHC infrastructure, including centralized pathology Multiplexed quantitative ImmunoFluorescence via Vectra Polaris Validated and custom multiplex panels EXPLORE

QuartzBio^SM Qb Harmonize biomarker data from multiple labs and EDC Deep multiomic visualization and analysis expertise AI-derived multiomic signatures across data sets EXPLORE

Large Molecule Bioanalysis Ba Global experts in immune assessments and immunogenicity Comprehensive analytical support for complex biologics – bispecifics, ADCs, and gene therapy EXPLORE

Liquid Biopsy Lb Capture CTCs / cell-free DNA, and prepare cells for downstream assays of any type utilizing Apostream - a proprietary cell separation and enrichment platform Phenotype rare cells Analyze multiple genomic biomarkers EXPLORE

Global Lab Network Pln Globally located labs to support all required quality systems for any application GxP, CAP, CLIA, ISO for preclinical, clinical, and commercial applications EXPLORE

We are the world’s most comprehensive services organization for
biomarker-driven therapeutic and diagnostic development.

Our scientific team leverages innovative technologies to rapidly interrogate biomarker data so you can stratify patients, identify novel drug targets, characterize MoA, and swiftly reach actionable information.
- Translational informatics
- Biometrics
× EXPLORE TRANSLATIONAL INFORMATICS AND BIOMETRICS
Full-service oncology trial solutions speed the journey from preclinical to first-in-man to post-market.
- Early phase oncology site network for predictable start-up and performance
- Highly experienced oncology-only trial team
- Accelerated pathway to proof of concept
- Patient stratification assays
- Translational bioinformatics and innovative data delivery
- Immune monitoring
× EXPLORE ONCOLOGY SOLUTIONS
Spend more time on research and less time searching for unique human donors.
- Healthy human PBMCs characterized for HLA Class I and II
- Demonstrated functionality
- Purified primary cells (such as monocytes, NK, and Tregulatory cells)
- Disease state PBMCs
- Leukopaks
× EXPLORE BIOMATERIALS
Scientists, informaticists, and global logistics teams work in concert to collect, assay, and interpret highly complex biological data.
- Advanced custom cell-based and ligand-binding assays
- Global biorepositories and biobanking
- Comprehensive immune monitoring
- Bioanalytical services for large molecules
- Consistent global specimen collection and processing for accurate results
× EXPLORE SPECIALTY LAB SERVICES
End-to-end expertise informs every point on the product pathway.
- Clinical trials for diagnostics and medical devices
- Regulatory strategy development and execution
- Market access and evidence strategies
- Regulatory and clinical utility study design
× EXPLORE DIAGNOSTICS AND MEDICAL DEVICE SOLUTIONS
End-to-end solutions for developing treatments for rare diseases, from regulatory strategy and protocol design and conduct of global clinical trials to successful regulatory agency submissions.
- Specialized expertise in rare diseases and complex trials
- Complete regulatory support, including orphan drug applications
- Protocol development
- Biostatistics and database design for small patient populations
- Pioneering approaches to patient recruitment and engagement
- In-depth knowledge of FDA and EMA requirements
- Single resource for biomarkers linked to a disease
× EXPLORE RARE AND ORPHAN SOLUTIONS

The new science of accelerating innovation

Omics + big data + biomarker-guided drug development. It’s a new reality, bringing unprecedented abilities to interrogate and translate biological information—and unprecedented opportunities for life sciences companies to achieve their goals faster and more cost-effectively. This fundamental shift requires a new approach to drug development. Precision for Medicine is leading the way.

Explore our services

Translational Informatics and Biometrics
Oncology Solutions
Biomaterials
Specialty Lab Services
Diagnostics and Medical Device Solutions
Rare and Orphan Solutions

« Back

News

Biomarker-driven clinical research.
It’s elemental.

We are the world’s most comprehensive services organization for biomarker-driven therapeutic and diagnostic development.

We are the world’s most comprehensive services organization for
biomarker-driven therapeutic and diagnostic development.

Our scientific team leverages innovative technologies to rapidly interrogate biomarker data so you can stratify patients, identify novel drug targets, characterize MoA, and swiftly reach actionable information.

Full-service oncology trial solutions speed the journey from preclinical to first-in-man to post-market.

Spend more time on research and less time searching for unique human donors.

Scientists, informaticists, and global logistics teams work in concert to collect, assay, and interpret highly complex biological data.

End-to-end expertise informs every point on the product pathway.

End-to-end solutions for developing treatments for rare diseases, from regulatory strategy and protocol design and conduct of global clinical trials to successful regulatory agency submissions.

The new science of accelerating innovation

Precision for Medicine Receives CIR (French Research Tax Credit) Accreditation

Precision for Medicine launches biospecimen solutions offering with acquisition of ProMedDx and GLAS

QuartzBio™, part of Precision for Medicine, Expands Computational Biology and Launches Boston Office

Biomarker-driven clinical research. It’s elemental.

We are the world’s most comprehensive services organization for biomarker-driven therapeutic and diagnostic development.

We are the world’s most comprehensive services organization for biomarker-driven therapeutic and diagnostic development.

Our scientific team leverages innovative technologies to rapidly interrogate biomarker data so you can stratify patients, identify novel drug targets, characterize MoA, and swiftly reach actionable information.

Full-service oncology trial solutions speed the journey from preclinical to first-in-man to post-market.

Spend more time on research and less time searching for unique human donors.

Scientists, informaticists, and global logistics teams work in concert to collect, assay, and interpret highly complex biological data.

End-to-end expertise informs every point on the product pathway.

End-to-end solutions for developing treatments for rare diseases, from regulatory strategy and protocol design and conduct of global clinical trials to successful regulatory agency submissions.

The new science of accelerating innovation

Precision for Medicine Receives CIR (French Research Tax Credit) Accreditation

Precision for Medicine launches biospecimen solutions offering with acquisition of ProMedDx and GLAS

QuartzBio™, part of Precision for Medicine, Expands Computational Biology and Launches Boston Office

Biomarker-driven clinical research.
It’s elemental.

We are the world’s most comprehensive services organization for
biomarker-driven therapeutic and diagnostic development.